Monitoring recurrent angioedema: Findings from the Turkish angioedema control test validation study.

"CONFLICT OF INTEREST STATEMENT The authors declare that they have no relevant or material financial interests that relate to the data and research described in this publication. Emek Kocatürk has received honoraria from Novartis, Menarini, Pfizer, Sanofi, La Roche Posey and Abdi İbrahim. Bahar Sevimli Dikicier has received honoraria from Novartis. Marcus Maurer or recently was a speaker and/or advisor for and/or has received research funding from Allakos, Allvotech, Amgen, Aquestive, Aralez, AstraZeneca, Astria, Bayer, BioCryst, Celldex, Celltrion, CSL Behring, Evommune, GSK, Ipsen, Kalvista, Leo Pharma, Lilly, Menarini, Mitsubishi Tanabe Pharma, Moxie, Noucor, Novartis, Orion, Biotechnology, Pharvaris, Resonance Medicine, Sanofi/Regeneron, Septerna, Takeda, Teva, Third HarmonicBio, Trial Form support International AB, ValenzaBio, Yuhan Corporation and Zurabio. Karsten Weller is or was recently an advisor for Novartis and has received honoraria from Moxie, Takeda, Novartis, CSL Behring and Biocryst."